247 related articles for article (PubMed ID: 14674665)
1. Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.
Gambaro C; Bilardi C; Dulbecco P; Iiritano E; Zentilin P; Mansia C; Usai P; Vigneri S; Savarino V
Dig Liver Dis; 2003 Nov; 35(11):763-7. PubMed ID: 14674665
[TBL] [Abstract][Full Text] [Related]
2. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Bochenek WJ; Peters S; Fraga PD; Wang W; Mack ME; Osato MS; El-Zimaity HM; Davis KD; Graham DY;
Helicobacter; 2003 Dec; 8(6):626-42. PubMed ID: 14632678
[TBL] [Abstract][Full Text] [Related]
3. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
[TBL] [Abstract][Full Text] [Related]
4. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Lüth S; Teyssen S; Kölbel CB; Singer MV
Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
[TBL] [Abstract][Full Text] [Related]
5. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
De Francesco V; Zullo A; Hassan C; Della Valle N; Pietrini L; Minenna MF; Winn S; Monno R; Stoppino V; Morini S; Panella C; Ierardi E
Dig Liver Dis; 2004 May; 36(5):322-6. PubMed ID: 15191200
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.
Sun WH; Ou XL; Cao DZ; Yu Q; Yu T; Hu JM; Zhu F; Sun YL; Fu XL; Su H
World J Gastroenterol; 2005 Apr; 11(16):2477-81. PubMed ID: 15832421
[TBL] [Abstract][Full Text] [Related]
7. [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
Choi BK; Yang SY; Park ET; Jang YS; Lee YJ; Lee SH; Seol SY; Chung JM
Korean J Gastroenterol; 2003 Aug; 42(2):102-7. PubMed ID: 14532713
[TBL] [Abstract][Full Text] [Related]
8. Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.
Nagahara A; Miwa H; Yamada T; Kurosawa A; Ohkura R; Sato N
Aliment Pharmacol Ther; 2001 Mar; 15(3):417-21. PubMed ID: 11207518
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
[TBL] [Abstract][Full Text] [Related]
10. Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
Calvet X; Ducons J; Bujanda L; Bory F; Montserrat A; Gisbert JP;
Am J Gastroenterol; 2005 Aug; 100(8):1696-701. PubMed ID: 16086704
[TBL] [Abstract][Full Text] [Related]
11. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
Nagahara A; Miwa H; Ogawa K; Kurosawa A; Ohkura R; Iida N; Sato N
Helicobacter; 2000 Jun; 5(2):88-93. PubMed ID: 10849057
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
[TBL] [Abstract][Full Text] [Related]
13. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
17. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
[TBL] [Abstract][Full Text] [Related]
18. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
